These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 29194722)
1. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response. Wang W; Wang Y; Qu C; Wang S; Zhou J; Cao W; Xu L; Ma B; Hakim MS; Yin Y; Li T; Peppelenbosch MP; Zhao J; Pan Q Hepatology; 2018 Jun; 67(6):2096-2112. PubMed ID: 29194722 [TBL] [Abstract][Full Text] [Related]
2. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391 [TBL] [Abstract][Full Text] [Related]
3. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication. Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761 [TBL] [Abstract][Full Text] [Related]
4. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner. Sooryanarain H; Heffron CL; Meng XJ mBio; 2020 Jan; 11(1):. PubMed ID: 31937650 [TBL] [Abstract][Full Text] [Related]
5. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122. Haldipur B; Bhukya PL; Arankalle V; Lole K J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601 [TBL] [Abstract][Full Text] [Related]
6. Suppression of interferon-α signaling by hepatitis E virus. Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878 [TBL] [Abstract][Full Text] [Related]
7. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms. Kang S; Myoung J J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236 [TBL] [Abstract][Full Text] [Related]
8. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication. Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637 [TBL] [Abstract][Full Text] [Related]
9. The Capsid Protein of Hepatitis E Virus Inhibits Interferon Induction via Its N-terminal Arginine-Rich Motif. Lin S; Yang Y; Nan Y; Ma Z; Yang L; Zhang YJ Viruses; 2019 Nov; 11(11):. PubMed ID: 31717991 [TBL] [Abstract][Full Text] [Related]
10. Advances in Hepatitis E Virus Biology and Pathogenesis. Lin S; Zhang YJ Viruses; 2021 Feb; 13(2):. PubMed ID: 33572257 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus persists in the presence of a type III interferon response. Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073 [TBL] [Abstract][Full Text] [Related]
12. IFN-λ3 as a host immune response in acute hepatitis E virus infection. Murata K; Kang JH; Nagashima S; Matsui T; Karino Y; Yamamoto Y; Atarashi T; Oohara M; Uebayashi M; Sakata H; Matsubayashi K; Takahashi K; Arai M; Mishiro S; Sugiyama M; Mizokami M; Okamoto H Cytokine; 2020 Jan; 125():154816. PubMed ID: 31465972 [TBL] [Abstract][Full Text] [Related]
13. Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth. Li TC; Yoshizaki S; Kataoka M; Ami Y; Suzaki Y; Doan YH; Haga K; Ishii K; Takeda N; Wakita T Infect Genet Evol; 2017 Jul; 51():153-159. PubMed ID: 28347753 [TBL] [Abstract][Full Text] [Related]
14. Progesterone-Mediated Enhancement of Hepatitis E Virus Replication in Human Liver Cells. Sooryanarain H; Ahmed SA; Meng XJ mBio; 2021 Jun; 12(3):e0143421. PubMed ID: 34154410 [TBL] [Abstract][Full Text] [Related]
15. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection. Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360 [TBL] [Abstract][Full Text] [Related]
16. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver. Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186 [TBL] [Abstract][Full Text] [Related]
17. The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response. Bagdassarian E; Doceul V; Pellerin M; Demange A; Meyer L; Jouvenet N; Pavio N Viruses; 2018 Dec; 10(12):. PubMed ID: 30567349 [TBL] [Abstract][Full Text] [Related]
18. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671 [TBL] [Abstract][Full Text] [Related]
19. Study of cellular immune response against Hepatitis E virus (HEV). Prabhu SB; Gupta P; Durgapal H; Rath S; Gupta SD; Acharya SK; Panda SK J Viral Hepat; 2011 Aug; 18(8):587-94. PubMed ID: 20579277 [TBL] [Abstract][Full Text] [Related]
20. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development. Hakim MS; Ikram A; Zhou J; Wang W; Peppelenbosch MP; Pan Q Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29272060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]